• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Varian Medical Systems allies with optx

Article

Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx

Varian Medical Systems, a major manufacturer of integrated cancer therapy systems, is partnering with optx corporation, a leading developer of medical oncology treatment management software. Under the agreement, Varian will begin globally marketing optx software as a VARiS MedOncology module within its Generation 6 suite of oncology information products. The product will replace earlier versions of Varian’s VARiS MedOncology software. Installation and training for customers, as well as ongoing service and support, will be provided by optx. The optx software will help physicians craft chemotherapy regimens by providing standard and customizable treatment protocols. It will also enable physicians to record treatments and track results.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.